Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wellness devices show promise for long COVID relief

NCT ID NCT07190105

Symptom relief Sponsor: Leidos Life Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two wellness products that stimulate the vagus nerve—a key nerve for stress, mood, and inflammation—to see if they could help people with Long COVID. Over 500 participants used the devices and tracked their health with a Fitbit and surveys. The goal was to measure changes in symptoms like fatigue, anxiety, sleep problems, and heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

546 people

The number who actually took part.

Started

Oct 2025

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Tested positive by any test for acute COVID-19 and/or have ICD-10 code for COVID-19 in their electronic health records (EHR) 2. Any patient having the ICD-10 code for post-acute sequelae of COVID-19 (PASC) within their EHR, or any patient who has evidence of a Long COVID clinic visit within their EHR 3. Have persistent COVID-19 symptoms 3 months following resolution of acute COVID-19 infection as indicated by a negative COVID-19 test 4. Self-identified as having Long COVID based on symptomology: a. Symptoms must include any combination of the following: (ICD-10 codes shown): * Shortness of breath (R06.02, R06.00, or R06.09) * Fatigue (R53.83, or R53.82) * Cognitive impairment (G31.84 or R41.9) * Mental, Behavioral, and Neurodevelopmental disorders (F01-F99) * Postural orthostatic tachycardia syndrome (POTS) (I49.8) 5. Participants must have auditory headphones; over the ear headphones or earbuds 6. Participants must be at least 18 years of age, inclusive, at the time of signing the informed consent 7. Capable of understanding and providing signed informed consent 8. Participants must have a smart phone 9. Reliable access to internet via browser installed on a smartphone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Long COVID symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Long COVID symptoms

Contacts and locations

Locations

  • Virtual

    Frederick, Maryland, 21703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.